Alert: Major Price Decline (7/10/19)-DiaMedica Therapeutics Inc (NASDAQ: DMCAF).


DiaMedica Therapeutics Inc (NASDAQ: DMCAF) stock closed at $4.01 on 7/10/19 after a major decline of -10.7%. Moreover, unusually high trading volume at 172% of normal accompanied the decline. The stock has declined -17.5% during the last week and has been extremely weak relative to the market over the last nine months.


Current PriceTarget Research Rating

With future capital returns forecasted to be below the cost of capital, DMCAF is expected to be a major Value Eraser.

DMCAF is currently unrated.

Rating Review

The stock is currently unrated.

About John Lafferty 54938 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.